Vincristine cellular pharmacokinetic changes associated with multidrug resistance (original) (raw)

Uptake and binding of vincristine by murine leukemia cells

Biochemical Pharmacology, 1975

Pharmacokinetics of vindesine and vincristine in humans

Cancer research, 1977

Population pharmacokinetics and pharmacogenetics of vincristine in paediatric patients treated for solid tumour diseases

Bruno Lacarelle

Cancer Chemotherapy and Pharmacology, 2011

View PDFchevron_right

Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristine

Carles Domenech

British Journal of Pharmacology, 1988

View PDFchevron_right

Role of cell cholesterol in modulating vincristine uptake and resistance

Carles Domenech

International Journal of Cancer, 1993

View PDFchevron_right

Selective Enhancement of Vincristine Cytotoxicity in Multidrug-resistant l\imor Cells by Dilantin (Phenytoin)1

Aleck Hercbergs

2000

View PDFchevron_right

Selective Enhancement of Vincristine Cytotoxicity in Multidrug-resistant Tumor Cells by Dilantin (Phenytoin)

Aleck Hercbergs

Cancer Research, 1993

View PDFchevron_right

Haber M, Norris MD, Kavallaris M, Bell DR, Davey RA, White L, Stewart BWAtypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein. Cancer Res 49: 5281-5287

Les White

Cancer Research

View PDFchevron_right

Pharmacokinetics of vincristine sulfate in children

Sagar Iv

Cancer Chemotherapy and Pharmacology, 1981

View PDFchevron_right

Predictors of Vinorelbine Pharmacokinetics and Pharmacodynamics in Patients With Cancer

Howard Gurney

Journal of Clinical Oncology, 2006

View PDFchevron_right

Clinical trials of modulation of multidrug resistance pharmacokinetic and pharmacodynamic considerations

Sonja Kaubisch

Cancer, 1993

View PDFchevron_right

Overcoming of vincristine resistance in L1210/VCR cells by several corticosteroids. Collateral sensitivity of resistant cells

jan slezak

Neoplasma, 1993

View PDFchevron_right

Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cells

Anna Janowska-Wieczorek

Cancer Research

View PDFchevron_right

Clinical Pharmacokinetics and Effects of Vincristine Sulfate in Dogs with Transmissible Venereal Tumor (TVT)

Sunee Kunakornsawat

Journal of Veterinary Medical Science, 2014

View PDFchevron_right

Multidrug resistance-associated protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and Buthionine sulfoximine

Selma Akan, Tomris Ozben, Burhan Savas

Cancer cell international, 2005

View PDFchevron_right

Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells

Torben Skovsgaard

Cancer research, 1978

View PDFchevron_right

Reversal of P-glycoprotein mediated vincristine resistance of L1210/VCR cells by analogues of pentoxifylline

Zuzana Drobna

European Journal of Pharmaceutical Sciences, 2004

View PDFchevron_right

Tunicamycin potentiates drug cytotoxicity and vincristine retention in multidrug resistant cell lines

Donavon Hiss

European Journal of Cancer, 1996

View PDFchevron_right

L1210 cells cultivated under the selection pressure of doxorubicin or vincristine express common mechanisms of multidrug resistance based on the overexpression of P-glycoprotein

P H, Ima Dovinova

Toxicology in Vitro, 2006

View PDFchevron_right

Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein

Ross Davey

Cancer research, 1989

View PDFchevron_right

Vinblastine pharmacokinetics in mouse, dog, and human in the context of a physiologically based model incorporating tissue‐specific drug binding, transport, and metabolism

Sandra Witta

Pharmacology Research & Perspectives

View PDFchevron_right

Vincristine in Combination Therapy of Cancer: Emerging Trends in Clinics

Jan Škubník

Biology

View PDFchevron_right

Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione

Roger Deeley

Cancer research, 1998

View PDFchevron_right

Molecular mechanisms of vincristine and paclitaxel resistance in mcf-7 cell line

Meltem Kars

2008

View PDFchevron_right

Investigations of the metabolic fate of tritiated vincristine in the rat by high-pressure liquid chromatography

Mary Ann Castle

Biochemical Pharmacology, 1978

View PDFchevron_right

Mechanism of multidrug resistance in human tumour cell lines and complete reversion of cellular resistance

Giuseppe Toffoli

European Journal of Cancer, 1992

View PDFchevron_right

Pharmacologic circumvention of multidrug resistance

James Ford

Cytotechnology, 1993

View PDFchevron_right

Analysis of Drug Transport Kinetics in Multidrug-Resistant Cells Using a Novel Coumarin-Vinblastine Compound

William Bornmann

Biochemistry, 1994

View PDFchevron_right

Atypical Multidrug Resistance in a Therapy-induced Drug-resistant Human Leukemia Cell Line (LALW-2): Resistance to Vinca Alkaloids Independent of P-Glycoprotein1

Ross Davey

2000

View PDFchevron_right

Analysis of Drug Transport Kinetics in Multidrug-resistant Cells: Implications for Drug Action

Milena Salerno

Current Medicinal Chemistry, 2001

View PDFchevron_right

In Vivo Reversal of Multidrug Resistance by Two New Dihydropyridine Derivatives, S16317 and S16324

Laurence Kraus-berthier

Acta Oncologica, 1994

View PDFchevron_right

Mechanisms of resistance to combinations of vincristine, etoposide and doxorubicin in Chinese hamster ovary cells

Jean-Yves CHARCOSSET

British Journal of Cancer, 1995

View PDFchevron_right

Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro

Jean-Marc Barret

Investigational new drugs, 1998

View PDFchevron_right

Reversal of MRP-mediated vincristine resistance in KB cells by buthionine sulfoximine in combination with PAK-104P

Tatsuhiko Furukawa

Cancer Letters, 1998

View PDFchevron_right

Intracellular drug sequestration events associated with the emergence of multidrug resistance: a mechanistic review

Muralikrishna Duvvuri

Frontiers in Bioscience, 2005

View PDFchevron_right

Vincristine cellular pharmacokinetic changes associated with multidrug resistance (original) (raw)

Related papers